Drugs / Bramitob®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01116089 Comparator | Jul 2010 → Oct 2011 | cystic fibrosis | Chiesi Farmaceutici S.p.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bramitob | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01116089 ↗ |
| Route | Inhaled | “solution administered by inhalation twice daily for 28 days” NCT01116089 ↗ |